48
Participants
Start Date
March 1, 2024
Primary Completion Date
January 15, 2025
Study Completion Date
January 15, 2027
Sufentanil
Induction: sufentanil TCI 0.3 ng/ml Maintenance: sufentanil TCI 0.05-0.5 ng/ml
Remifentanil
Induction: remifentanil TCI 3 ng/ml Maintenance: remifentanil TCI 0.5-5 ng/ml
Seoul National University Bundang Hospital, Seongnam
Seoul National University Hospital
OTHER